Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML133 hydrochloride (ML133 HCl) 是选择性的Kir2家族通道抑制剂,在pH 7.4 和pH 8.5 时的IC50值分别为1.8 μM 和290 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 185 | 现货 | ||
5 mg | ¥ 398 | 现货 | ||
10 mg | ¥ 518 | 现货 | ||
25 mg | ¥ 987 | 现货 | ||
50 mg | ¥ 1,730 | 现货 | ||
100 mg | ¥ 2,890 | 现货 | ||
200 mg | ¥ 4,220 | 现货 | ||
500 mg | ¥ 6,590 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 398 | 现货 |
产品描述 | ML133 hydrochloride (ML133 HCl) is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 μM (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1. |
靶点活性 | KIR2.1 (pH 8.5):290 nM, KIR2.1 (pH 7.4):1.8 μM |
体外活性 | The ratio of total concentration of extracellular ML133 versus intracellular ML133 is 1:0.13 at pH 6.5, 1:9.09 at pH 8.5. ML133 is clean against 3A4 and 2C9 (IC50 >30 μM), displays moderate inhibition of 1A2 (IC50 = 3.3 μM) but proves to be a potent inhibitor of 2D6 (IC50 = 0.13 μM) in CYP450 assay. ML133 is highly protein bound (>99%) in both human and rat and also displays high intrinsic clearance in both species. ML133 (10 μM) is not displaced by K+ influx from the wild-type Kir2.1 in HEK 293 cells. M1 and/or M2 transmembrane domains contain the critical molecular determinant for ML133 inhibition of Kir2.1, especially D172 and I176. [1] |
别名 | ML133 HCl, (4-甲氧基苄基)(1-萘基甲基)胺盐酸盐 |
分子量 | 313.82 |
分子式 | C19H19NO·HCl |
CAS No. | 1222781-70-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 31.4 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.1865 mL | 15.9327 mL | 31.8654 mL | 79.6635 mL |
5 mM | 0.6373 mL | 3.1865 mL | 6.3731 mL | 15.9327 mL | |
10 mM | 0.3187 mL | 1.5933 mL | 3.1865 mL | 7.9664 mL | |
20 mM | 0.1593 mL | 0.7966 mL | 1.5933 mL | 3.9832 mL | |
50 mM | 0.0637 mL | 0.3187 mL | 0.6373 mL | 1.5933 mL | |
100 mM | 0.0319 mL | 0.1593 mL | 0.3187 mL | 0.7966 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
ML133 hydrochloride 1222781-70-5 Membrane transporter/Ion channel Potassium Channel ML133 HCl KcsA Inhibitor inhibit ML 133 Hydrochloride ML-133 Hydrochloride ML 133 ML-133 hydrochloride ML133 ML133 Hydrochloride (4-甲氧基苄基)(1-萘基甲基)胺盐酸盐 ML-133 inhibitor